Opinion

... in response to LDL Cholesterol and Heart Disease
  1. I find a "current and recent grants" declaration from fellow Cholesterol
    Anthony Capitan Anthony Capitan United States says:
    February 19, 2020 at 5:35 PM

    I find a "current and recent grants" declaration from fellow Cholesterol Treatment Trialists' (CTT) Collaboration secretariat member, Colin Baigent, to be particularly enlightening (ref 5):

    Merck & Schering £39M;
    Merck £52M;
    British Heart Foundation £9M + £2.7M;
    Medical Research Council £13.8M - recent council appointees being Senior Vice-President and Chief Scientific Officer of Pfizer Neusentis, and Executive Vice President of Innovative Medicines at AstraZeneca (ref 6).
    Bayer £965,000
    Solvay £978,000

    That’s £116 MILLION before you get into the small change.

    Ref 1 www.medicines.org.uk/.../Lipitor+10mg,+20mg,+40...

    Ref 2 usatoday30.usatoday.com/.../treatm...

    Ref 3 www.lipidsonline.org/site/editorial.cfm#collins

    Ref 4 www.ncbi.nlm.nih.gov/pmc/articles/PMC3437972/

    Ref 5 www.britishrenal.org/.../...5f-40fb-b6ba-81201b... (See page 5)

    Ref 6 www.mrc.ac.uk/Newspublications/News/MRC008756

    Reply
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback